These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
301 related articles for article (PubMed ID: 31375664)
1. Pluripotency reprogramming by competent and incompetent POU factors uncovers temporal dependency for Oct4 and Sox2. Malik V; Glaser LV; Zimmer D; Velychko S; Weng M; Holzner M; Arend M; Chen Y; Srivastava Y; Veerapandian V; Shah Z; Esteban MA; Wang H; Chen J; Schöler HR; Hutchins AP; Meijsing SH; Pott S; Jauch R Nat Commun; 2019 Aug; 10(1):3477. PubMed ID: 31375664 [TBL] [Abstract][Full Text] [Related]
2. Sox2 and Klf4 as the Functional Core in Pluripotency Induction without Exogenous Oct4. An Z; Liu P; Zheng J; Si C; Li T; Chen Y; Ma T; Zhang MQ; Zhou Q; Ding S Cell Rep; 2019 Nov; 29(7):1986-2000.e8. PubMed ID: 31722212 [TBL] [Abstract][Full Text] [Related]
3. Changing POU dimerization preferences converts Oct6 into a pluripotency inducer. Jerabek S; Ng CK; Wu G; Arauzo-Bravo MJ; Kim KP; Esch D; Malik V; Chen Y; Velychko S; MacCarthy CM; Yang X; Cojocaru V; Schöler HR; Jauch R EMBO Rep; 2017 Feb; 18(2):319-333. PubMed ID: 28007765 [TBL] [Abstract][Full Text] [Related]
4. Critical POU domain residues confer Oct4 uniqueness in somatic cell reprogramming. Jin W; Wang L; Zhu F; Tan W; Lin W; Chen D; Sun Q; Xia Z Sci Rep; 2016 Feb; 6():20818. PubMed ID: 26877091 [TBL] [Abstract][Full Text] [Related]
5. Klf4 interacts directly with Oct4 and Sox2 to promote reprogramming. Wei Z; Yang Y; Zhang P; Andrianakos R; Hasegawa K; Lyu J; Chen X; Bai G; Liu C; Pera M; Lu W Stem Cells; 2009 Dec; 27(12):2969-78. PubMed ID: 19816951 [TBL] [Abstract][Full Text] [Related]
6. A role for mitotic bookmarking of SOX2 in pluripotency and differentiation. Deluz C; Friman ET; Strebinger D; Benke A; Raccaud M; Callegari A; Leleu M; Manley S; Suter DM Genes Dev; 2016 Nov; 30(22):2538-2550. PubMed ID: 27920086 [TBL] [Abstract][Full Text] [Related]
7. OCT4 and SOX2 Work as Transcriptional Activators in Reprogramming Human Fibroblasts. Narayan S; Bryant G; Shah S; Berrozpe G; Ptashne M Cell Rep; 2017 Aug; 20(7):1585-1596. PubMed ID: 28813671 [TBL] [Abstract][Full Text] [Related]
9. The nuclear receptor Nr5a2 can replace Oct4 in the reprogramming of murine somatic cells to pluripotent cells. Heng JC; Feng B; Han J; Jiang J; Kraus P; Ng JH; Orlov YL; Huss M; Yang L; Lufkin T; Lim B; Ng HH Cell Stem Cell; 2010 Feb; 6(2):167-74. PubMed ID: 20096661 [TBL] [Abstract][Full Text] [Related]
11. C/EBPα poises B cells for rapid reprogramming into induced pluripotent stem cells. Di Stefano B; Sardina JL; van Oevelen C; Collombet S; Kallin EM; Vicent GP; Lu J; Thieffry D; Beato M; Graf T Nature; 2014 Feb; 506(7487):235-9. PubMed ID: 24336202 [TBL] [Abstract][Full Text] [Related]
12. CRISPR-Based Chromatin Remodeling of the Endogenous Oct4 or Sox2 Locus Enables Reprogramming to Pluripotency. Liu P; Chen M; Liu Y; Qi LS; Ding S Cell Stem Cell; 2018 Feb; 22(2):252-261.e4. PubMed ID: 29358044 [TBL] [Abstract][Full Text] [Related]
13. Cooperative Binding of Transcription Factors Orchestrates Reprogramming. Chronis C; Fiziev P; Papp B; Butz S; Bonora G; Sabri S; Ernst J; Plath K Cell; 2017 Jan; 168(3):442-459.e20. PubMed ID: 28111071 [TBL] [Abstract][Full Text] [Related]
14. Selective influence of Sox2 on POU transcription factor binding in embryonic and neural stem cells. Mistri TK; Devasia AG; Chu LT; Ng WP; Halbritter F; Colby D; Martynoga B; Tomlinson SR; Chambers I; Robson P; Wohland T EMBO Rep; 2015 Sep; 16(9):1177-91. PubMed ID: 26265007 [TBL] [Abstract][Full Text] [Related]
15. Excluding Oct4 from Yamanaka Cocktail Unleashes the Developmental Potential of iPSCs. Velychko S; Adachi K; Kim KP; Hou Y; MacCarthy CM; Wu G; Schöler HR Cell Stem Cell; 2019 Dec; 25(6):737-753.e4. PubMed ID: 31708402 [TBL] [Abstract][Full Text] [Related]
16. Chromatin lncRNA Platr10 controls stem cell pluripotency by coordinating an intrachromosomal regulatory network. Du Z; Wen X; Wang Y; Jia L; Zhang S; Liu Y; Zhou L; Li H; Yang W; Wang C; Chen J; Hao Y; Salgado Figueroa D; Chen H; Li D; Chen N; Celik I; Zhu Y; Yan Z; Fu C; Liu S; Jiao B; Wang Z; Zhang H; Gülsoy G; Luo J; Qin B; Gao S; Kapranov P; Esteban MA; Zhang S; Li W; Ay F; Chen R; Hoffman AR; Cui J; Hu JF Genome Biol; 2021 Aug; 22(1):233. PubMed ID: 34412677 [TBL] [Abstract][Full Text] [Related]
17. Human Ocular Epithelial Cells Endogenously Expressing SOX2 and OCT4 Yield High Efficiency of Pluripotency Reprogramming. Poon MW; He J; Fang X; Zhang Z; Wang W; Wang J; Qiu F; Tse HF; Li W; Liu Z; Lian Q PLoS One; 2015; 10(7):e0131288. PubMed ID: 26131692 [TBL] [Abstract][Full Text] [Related]
18. Oct4-enhanced green fluorescent protein transgenic pigs: a new large animal model for reprogramming studies. Nowak-Imialek M; Kues WA; Petersen B; Lucas-Hahn A; Herrmann D; Haridoss S; Oropeza M; Lemme E; Schöler HR; Carnwath JW; Niemann H Stem Cells Dev; 2011 Sep; 20(9):1563-75. PubMed ID: 21126163 [TBL] [Abstract][Full Text] [Related]
19. Cancer-associated missense mutations enhance the pluripotency reprogramming activity of OCT4 and SOX17. Srivastava Y; Tan DS; Malik V; Weng M; Javed A; Cojocaru V; Wu G; Veerapandian V; Cheung LWT; Jauch R FEBS J; 2020 Jan; 287(1):122-144. PubMed ID: 31569299 [TBL] [Abstract][Full Text] [Related]
20. Dynamical reorganization of the pluripotency transcription factors Oct4 and Sox2 during early differentiation of embryonic stem cells. Verneri P; Vazquez Echegaray C; Oses C; Stortz M; Guberman A; Levi V Sci Rep; 2020 Mar; 10(1):5195. PubMed ID: 32251342 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]